Eli Lilly and Company
METHODS OF TREATING CROHN'S DISEASE
Last updated:
Abstract:
The present invention generally relates to the treatment of Crohn's Disease with an anti-IL-23p19 antibody, particularly dosage regimens for the treatment of the disease.
Status:
Application
Type:
Utility
Filling date:
21 Oct 2021
Issue date:
10 Feb 2022